Founded in 2020, CrisprBits operates in Health Tech industry. Initially focusing on developing precise gene-editing technologies, the company has evolved to offer a wider array of applications in diag...
Funding stage:
Pre-Series A
Last funding:
24/11/2025
Total funding:
$3.25 Mn+
Revenue:
Investors
Employee count:
42
Last 90d
42
Last 90d
Web traffic:
1.09K
1.09K
Last 30d
Last 30d
CrisprBits: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders11
Latest Filing Date30 March 2023- Funding Events13
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of CrisprBits
As of 31 March 2023, CrisprBits's equity is held by 10 shareholders, with the top three being Vijay Chandru, Rajeev Kohli, and Sunil Arora.
Vijay Chandru holds the largest stake in CrisprBits at 28.1% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 28.1% equity in CrisprBits.
As of 31 March 2023, investors collectively hold 67.6% equity in CrisprBits.
CrisprBits's ESOP pool stands at 4.4% of total equity as of 31 March 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links